News for Medtronic plc (MDT)

Medtronic (MDT) investors have an opportunity to enhance their investment strategies with advanced tools and expert analysis. The Fly now offers its timely stoc

BTIG analyst Ryan Zimmerman maintains a Neutral stance on Medtronic (MDT) following the Centers for Medicare and Medicaid Services (CMS) proposal for national c

Medtronic (MDT) has recently seen unusual activity in its options trading. This surge in interest highlights a significant change in the investment patterns for

Stifel has reiterated its Hold rating on Medtronic (MDT), setting a price target of $87 for the medical technology company. A proposal from the Centers for Medi

JPMorgan maintains a Neutral stance on Medtronic (MDT) following a proposal from the Centers for Medicare and Medicaid Services regarding national coverage for

The Centers for Medicare and Medicaid Services (CMS) announced that it has received a comprehensive, formal application to cover renal denervation. This innovat

Hewlett Packard Enterprise is training finance professionals to work with AI agents.

On July 9, 2025, Citigroup maintained its "Buy" rating on Medtronic (MDT) while adjusting its price target for the stock. The updated price target has been rais

Summary Medtronic PLC (MDT) recently announced a unique collaboration with the Wildlife Science Center and the Smithsonian's National Zoo and Conservation Biolo

Citi analyst Joanne Wuensch has increased the price target for Medtronic (MDT) to $99, slightly up from the previous $98, while maintaining a Buy rating on the

The company counts NATO and OpenAI among its prominent and wide-ranging client pool.

Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.

The lack of details about which countries are involved and which companies will be impacted as a result of the new trade deal announcements reflects ongoing uncertainty.

Medtronic plc (NYSE:MDT) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Wolfe Research analyst Mike Polark recently upgraded Medtronic plc (NYSE:MDT) from Underperform to Peer Perform, citing short-term upside potential while maintaining a cautious long-term outlook. In a note to investors, Polark clarified that this is not a […]

Medtronic's growth strategies, dividend stability, and innovation focus amidst debt concerns and market risks. Click here to read an analysis of MDT stock now.

The CFO role remains a key leadership position and strategic partner.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Medtronic plc (NYSE:MDT) is one of the 11 best European stocks to invest in. On June 23, the company announced the appointment of Dr. Joon Sup Lee as an independent director to its Board of Directors. The appointment went into effect on June 18, 2025. Dr. Lee’s appointment was a result of Medtronic increasing the […]

Medtronic plc (NYSE:MDT) is one of the Best Wide Moat Dividend Stocks to Invest in. The company remains a major player in the medical technology space as it focuses on medical devices. Its broad product lineup targets a variety of chronic conditions, including heart disease, diabetes, chronic pain, and acute care needs. With strengths across […]